The largest database of trusted experimental protocols

Q sepharose anion exchange chromatography

Manufactured by GE Healthcare
Sourced in Germany

Q-Sepharose is an anion-exchange chromatography resin produced by GE Healthcare. It is designed for the purification of biomolecules, such as proteins and nucleic acids, from complex samples. The resin consists of a cross-linked agarose matrix with quaternary ammonium functional groups, which enable the capture and separation of negatively charged species based on their differential interactions with the resin.

Automatically generated - may contain errors

4 protocols using q sepharose anion exchange chromatography

1

Purification and Characterization of Malaria Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA corresponding to deletion constructs of PFA0660w and PfHsp70-x were PCR amplified, and cloned in pET-28a(+) bacterial expression vector before expression in E. coli BL21 (DE3) cells. Recombinant proteins were purified using Ni-NTA affinity chromatography followed by gel permeation chromatography. Gel filtration chromatography was performed using AKTA prime plus on Superdex 200 10/300 GL column (GE Healthcare Life Sciences, Chicago, IL, USA). Purified PFA0660w-S was used for raising polyclonal antibodies in rabbits commercially (Merck, Bangalore, India).
To confirm protein identity, purified recombinant protein constructs of PFA0660w and PfHsp70-x were resolved on SDS-PAGE and transferred on NC membrane. NC membrane was blocked overnight at 4 °C in 5% BSA. Following washing, the blot was probed with horseradish peroxidise (HRP) linked monoclonal anti-hexahistidine antibody (1:2000; Sigma) for 2 hours, and developed with diamino benzidine/H2O2 substrate (Sigma).
Recombinant ATS domain of PF08_0141 was purified for experiments as previously described36 ,37 (link). Briefly, protein was purified using Ni-NTA affinity chromatography followed by Q-Sepharose anion exchange chromatography (GE Healthcare) and then size exclusion on Superdex 200 10/300 GL column (GE Healthcare).
+ Open protocol
+ Expand
2

Purification of Recombinant TcdB Toxin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant TcdB was expressed and purified as previously described (48 (link)). Briefly, a plasmid encoding His-tagged TcdB (pBL377) was transformed into Bacillus megaterium according to the manufacturer’s protocol (MoBiTec). Six liters of Luria-Bertani medium supplemented with tetracycline (10 mg/liter) were inoculated with an overnight culture to an OD600 of ∼0.1. Cells were grown at 37°C and 220 rpm. Expression was induced with 5 g/liter of d-xylose once cells reached an OD600 of 0.3 to 0.5. After 4 hours, the cells were centrifuged and resuspended in 20 mM tris (pH 8.0), 500 mM NaCl, and protease inhibitors. An EmulsiFlex C3 microfluidizer (Avestin) was used at 15,000 lb/in2 twice to generate lysates. Lysates were then centrifuged at 40,000g for 20 min. Supernatant containing toxin was passed through a Ni-affinity column (HisTrap FastFlow Crude, GE Healthcare) initially. Further purification was performed using Q-Sepharose anion-exchange chromatography (GE Healthcare) and gel filtration chromatography in 20 mM Hepes (pH 6.9)–50 mM NaCl.
+ Open protocol
+ Expand
3

Recombinant Influenza Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wt NA and mutant NA (I223R/H275Y) genes derived from A/H1N1 2009 pandemic influenza virus were amplified by PCR. The PCR products were cloned into the pAcGP67A vector (BD Biosciences) and transfected into the Sf9 insect cell line to produce recombinant proteins. The culture medium was collected, clarified by centrifugation at 110 × g, and subjected to further viral propagation. The cultured Sf9 cells were inoculated with recombinant baculovirus at a multiplicity of infection of 10 and incubated at 27 °C for 96 h. The cells were collected after centrifugation, and the cell pellet was resuspended in cell lysis buffer (50 mM Tris-HCl, pH 8.5, 5 mM 2-mercaptoethanol, 100 mM KCl, 1 mM phenylmethylsulfonyl fluoride), sonicated, and centrifuged at 16,000 × g for 15 min at 4 °C. After the cell lysate was sonicated to reduce its viscosity, the cell debris was removed by centrifugation for 1 h at 16,000 × g. The soluble protein from the cell supernatant was applied to Ni-nitrilotriacetic acid agarose resin (Qiagen), washed, and eluted with buffer (50 mM Tris-HCl, 0.5 M NaCl, 0.5 M imidazole, pH 8.0). The purified proteins were dialyzed against phosphate-buffered saline (PBS) and further purified by Q-Sepharose anion-exchange chromatography (GE Healthcare).
+ Open protocol
+ Expand
4

Relaxation Activity of DraTopoIB Modulated by PprA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant PprA and DraTopoIB expressed in E. coli BL21 (DE3) pLysS from pETpprA and pETtopoIB respectively, were purified from soluble fractions by metal affinity chromatography using NiNTA matrix (Qiagen Inc, Germany) followed by Q-sepharose anion exchange chromatography (GE Healthcare) using protocols as described earlier [29] . The DNA relaxation activity of DraTopoIB was monitored as described in [19] (link). In brief, 0.5 µM DraTopoIB was incubated in a reaction mixture containing 50 mM TrisHCl (pH 7.6), 100 mM NaCl, 5 mM MgCl2 and 500 ng supercoiled pUC18 DNA, in the presence of increasing concentrations of purified PprA as specified in the figure 4 legend. The reaction was carried out at 37°C for 30 min and quenched by heating at 65°C for 15 min in presence of 0.1%SDS. The products were analysed on 1% agarose gels, stained with ethidium bromide and DNA band intensity was measured densitometrically.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!